Amneal Pharmaceuticals Inc Class A (AMRX) returns
Amneal Pharmaceuticals returns over 10 years
$1,000 invested in Amneal Pharmaceuticals ten years ago was worth $1,039 at the close on October 30, 2026, with dividends reinvested: an average return of 0.4% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +6.8% | — | $1,068 | -0.9% |
| 3 months | +16.3% | — | $1,163 | +2.1% |
| Year to date | +70.7% | — | $1,707 | +11.7% |
| 1 year | +115.1% | — | $2,151 | +12.4% |
| 3 years | +454.4% | +77.0% | $5,544 | +88.5% |
| 5 years | +291.8% | +31.4% | $3,918 | +76.0% |
| 10 years | +3.9% | +0.4% | $1,039 | +316.6% |
Amneal Pharmaceuticals return by calendar year
| Year | AMRX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +70.7% | +11.7% | +59.0% |
| 2025 | +59.1% | +17.7% | +41.4% |
| 2024 | +30.5% | +24.9% | +5.6% |
| 2023 | +205.0% | +26.2% | +178.8% |
| 2022 | -58.5% | -18.2% | -40.3% |
| 2021 | +4.8% | +28.7% | -23.9% |
| 2020 | -5.2% | +18.4% | -23.6% |
| 2019 | -64.4% | +31.2% | -95.6% |
| 2018 | -18.7% | -4.6% | -14.2% |
| 2017 | +25.7% | +21.7% | +4.0% |
| 2016 | -69.0% | +12.0% | -81.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: AMRX financials · AMRX valuation
No forecast, no recommendation. This page describes Amneal Pharmaceuticals Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.